Back to XERS
Fortitude Family Office, LLC → XERS
Fortitude Family Office, LLC XERS Position History
Xeris Biopharma Holdings, Inc. • Healthcare
Quarters held
5
Latest value
$14K
Q3 2026
Peak value
$14K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13K |
| Q4 2025 | $12K |
| Q1 2026 | $9K |
| Q2 2026 | $12K |
| Q3 2026 | $14K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $14K | 1.5K | — | — |
| Q2 2026 | $12K | 1.5K | — | — |
| Q1 2026 | $9K | 1.6K | — | — |
| Q4 2025 | $12K | 1.6K | — | — |
| Q3 2025 | $13K | 1.6K | — | — |
Other funds holding XERS
Other Fortitude Family Office, LLC positions
ETHA
$50.9MISHARES CORE S&P 500 ETF
ETHA
$46.4MISHARES CORE S&P 500 ETF
VGES
$37.3MVANGUARD 0-3 MONTH TREASURY BILL ETF
ETHA
$36.4MISHARES CORE S&P 500 ETF
ETHA
$34.7MISHARES CORE S&P 500 ETF
ETHA
$33MISHARES CORE S&P 500 ETF
ETHA
$30.4MISHARES CORE MSCI INTERNATIONAL DEVELOPED MARKETS ETF
VGES
$29.8MVANGUARD 0-3 MONTH TREASURY BILL ETF